Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former Synthes Execs Get Prison Time For Unauthorized Spine Trial

This article was originally published in The Gray Sheet

Executive Summary

Federal authorities doled out prison time and fines to former executives of spinal fixation firm Synthes, and sent a broader warning to everyone in the industry about the penalties of corporate non-compliance for individuals.

You may also be interested in...



Prison Terms For Corporate Officers Over Food Violations Worry Pharma

Appeals court affirms sentencing of executives who pled guilty to FDCA misdemeanor violations for distribution of salmonella-contaminated eggs; split ruling finds that officers don't need to know they were violating law to be subject to imprisonment.

Regulatory News In Brief

International draft guidance on a single-audit program for device facilities is expected out by the end of the month, ECRI weighs in on UDI proposed rule, and more regulatory updates.

FDA Opens Device Criminal Investigations Under Pilot Program In 2011

Despite the name, FDA’s “Pharmaceutical Fraud Pilot Program” includes devices in its mission. Of the 16 criminal investigations opened under the program last year, two are explicitly focused on device companies.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel